EBC LE CONSEIL EUROPEEN DU CERVEAU
Desconocido
NeuroNanotech: Nanoplatforms for Neuroscience
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2023-DN-01
NeuroNanotech will train eleven researchers to tackle one of the major challenges in Europe’s ageing population - neurological diseases.
The...
2024-07-02 - 2028-12-31 | Financiado
2024-07-02 - 2028-12-31 | Financiado
BRAINTEASER: BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multipl...
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
H2020:
H2020-SC1-DTH-2018-2020
Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) are chronic diseases characterized by progressive or alternate impairment of...
2020-12-09 - 2024-12-31 | Financiado
2020-12-09 - 2024-12-31 | Financiado
PRIME: Prevention and Remediation of Insulin Multimorbidity in Europe
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
H2020:
H2020-SC1-BHC-2018-2020
PRIME introduces the novel concept of insulin signalling as a key mechanism underlying the multimorbidity of major mental and somatic illnes...
2019-12-06 - 2024-12-31 | Financiado
2019-12-06 - 2024-12-31 | Financiado
AD Detect-Prevent: Alzheimer s Disease AD Detect Prevent Presymptomatic AD detection and prevention
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
H2020:
H2020-EIC-FTI-2018-2020
Alzheimer’s disease (AD) is central to the rapidly growing and crushing ageing challenge that threatens to economically undermine today’s he...
2018-10-04 - 2022-04-30 | Financiado
2018-10-04 - 2022-04-30 | Financiado
ASCTN-Training: Training on Advanced Stem Cell Technologies in Neurology
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
H2020:
H2020-MSCA-ITN-2018
Neuronal disorders (NDs) are associated with behavioural and cognitive impairments and have a high prevalence. As such they are a high emoti...
2018-08-29 - 2023-03-31 | Financiado
2018-08-29 - 2023-03-31 | Financiado
MULTI-ACT: A Collective Research Impact Framework and multi variate models to foster the true engagement of act...
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
H2020:
H2020-SwafS-2016-17
Conventional accountability metrics to measure the impact of health R&I process normally are not able to represent the claims of different...
2018-04-18 - 2021-04-30 | Financiado
2018-04-18 - 2021-04-30 | Financiado
ADVANCE_HTA: Advancing and strengthening the methodological tools and practices relating to the application and i...
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
FP7:
The use of HTA has increased recently in Europe and more widely (e.g. Americas) to enable evidence-based coverage decisions and improve effi...
Financiado
Financiado
NERRI: Neuro Enhancement Responsible Research and Innovation
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
FP7:
This project aims to contribute to the introduction of Responsible Research and Innovation in neuro-enhancement (NE) in the European Researc...
Financiado
Financiado
PARADISE: Psychosocial fActors Relevant to BrAin DISorders in Europe
THE EUROPEAN BRAIN COUNCIL AISBL
participó en un
FP7:
The overall prevalence of brain disorders – both neurological and psychiatric – is very high in Europe. Although it is well known that the b...
Financiado
Financiado
* No se disponen de datos de la empresa actual.